Day 3 Post-Stroke: Oral Antihypertensives Are Preferred
On day 3 after stroke, oral antihypertensive therapy should be used rather than IV medications, as the patient is now beyond the acute phase where IV agents are indicated. The transition to oral therapy is both safe and reasonable at this timepoint for neurologically stable patients.
Clinical Reasoning
Timing and Route Selection
The 2018 AHA/ASA guidelines clearly delineate when IV versus oral antihypertensives are appropriate 1:
IV antihypertensives are reserved for:
- The hyperacute phase (first 24-48 hours)
- Patients requiring thrombolysis (BP must be <185/110 mmHg pre-tPA and <180/105 mmHg post-tPA)
- Hypertensive emergencies with end-organ damage (acute MI, heart failure, aortic dissection, symptomatic ICH)
- Patients who cannot swallow (dysphagia)
By day 3 post-stroke:
- The hyperacute phase has passed
- Most patients have experienced spontaneous BP decline
- Swallowing function can typically be assessed
- Neurological status should be stabilizing
Guideline-Based Approach
Starting or restarting antihypertensive therapy during hospitalization in patients with BP >140/90 mmHg who are neurologically stable is safe and reasonable to improve long-term BP control 1. The 2013 guidelines explicitly state that "it is reasonable to initiate long-term antihypertensive therapy after the initial 24 hours from stroke onset in most patients" 2.
The guidelines note that "controlled blood pressure lowering during acute stroke can best be achieved with intravenous antihypertensive therapies" 2, but this recommendation applies to the immediate post-stroke period when rapid, titratable control is needed—not to day 3.
Practical Implementation
For Neurologically Stable Patients on Day 3:
- Assess swallowing ability - If intact, proceed with oral medications
- Target BP >140/90 mmHg - Initiate or restart oral antihypertensives
- Choose appropriate oral agents based on:
- Comorbidities (heart failure, CAD, diabetes, CKD)
- Pre-stroke medication regimen
- Likelihood of adherence
When IV Therapy Might Still Be Needed on Day 3:
- Persistent dysphagia requiring tube feeding
- Neurological instability (stroke-in-evolution, fluctuating deficits)
- Severe hypertension (BP ≥220/120 mmHg) requiring urgent control
- Comorbid emergencies (acute heart failure, MI, aortic dissection)
Important Caveats
Recent Evidence Raises Concerns About IV Antihypertensives
A 2025 study found that IV antihypertensive use within 24 hours after successful thrombectomy was associated with worse functional outcomes (adjusted OR 0.51 for functional independence) and higher stroke-related mortality 3. While this specifically addresses post-thrombectomy patients, it reinforces the principle that aggressive IV BP lowering should be avoided unless clearly indicated.
Avoid Overly Aggressive BP Lowering
The evidence consistently shows that permissive hypertension is appropriate in acute ischemic stroke 4, 5, 6. By day 3, if BP is not severely elevated and the patient is stable, gentle oral therapy is preferred over aggressive IV control.
The Transition Strategy
The 2013 guidelines recommend temporarily discontinuing or reducing premorbid antihypertensives at stroke onset due to unpredictable responses during acute stress 2. By day 3, this acute stress period has passed, making it an appropriate time to restart oral medications.
Bottom Line
Use oral antihypertensives on day 3 post-stroke for neurologically stable patients with intact swallowing. Reserve IV agents only for patients with persistent dysphagia, neurological instability, or hypertensive emergencies requiring urgent control. The goal is long-term BP management, not acute crisis intervention at this timepoint.